{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-21-016275","form_type":"8-K","ticker":"HRMY","cik":"0001802665","company_name":"Harmony Biosciences Holdings, Inc.","filed_at":"2021-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.210989+00:00","generated_at":"2026-06-28T06:11:58.646754+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Harmony Biosciences appoints Linda Szyper to Board of Directors","bullets":["Linda Szyper, former COO of McCann Health, appointed as Class II director effective Nov 18, 2021.","She fills vacancy created by resignation of Eric L. Motley in August 2021.","Will serve on the Nominating and Corporate Governance Committee; deemed independent under Nasdaq.","Over 30 years experience in pharma marketing, commercialization, and healthcare communications."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-21-016275","json":"https://secwatch.observer/filing/0001558370-21-016275.json","markdown":"https://secwatch.observer/filing/0001558370-21-016275.md","text":"https://secwatch.observer/filing/0001558370-21-016275.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802665/000155837021016275/0001558370-21-016275-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802665/000155837021016275/hrmy-20211118x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T06:11:58.646754+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eabf893c3a","claim":"Linda Szyper was appointed as Class II director at Harmony Biosciences Holdings, Inc..","evidence_excerpt":"Effective November 18, 2021, the Board of Directors (the “Board”) of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Linda Szyper, age 56, as a Class II director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1802665/000155837021016275/0001558370-21-016275-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}